scholarly journals Targeting HER2 Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

2021 ◽  
pp. canres.1526.2021
Author(s):  
Han Han ◽  
Shuai Li ◽  
Ting Chen ◽  
Michael Fitzgerald ◽  
Shengwu Liu ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Insertion Mutant ◽  
Exon 20

MA11.02 Targeting HER2 Exon 20–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor, Mobocertinib

2021 ◽  
Vol 16 (10) ◽  
pp. S918
Author(s):  
H. Han ◽  
S. Li ◽  
T. Chen ◽  
M. Fitzgerald ◽  
S. Liu ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Exon 20

scholarly journals Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma

JCI Insight ◽  
2019 ◽  
Vol 4 (4) ◽  
Author(s):  
Rita Tohmé ◽  
Sudeh Izadmehr ◽  
Sai Gandhe ◽  
Giancarlo Tabaro ◽  
Sanjay Vallabhaneni ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Direct Activation
Sign in / Sign up

Export Citation Format

Share Document